Literature DB >> 1081459

Hemodynamic evaluation of patients with intrahepatic portal hypertension. Relationship between bleeding varices and the portohepatic gradient.

A Viallet, D Marleau, M Huet, F Martin, A Farley, J P Villeneuve, P Lavoie.   

Abstract

Between January 1970 and December 1974, 389 patients presenting an upper gastrointestinal hemorrhage had an emergency fiberoptic esophagogastroscopy at the time of bleeding. In 103 cases, esophageal and/or gastric varices were visualized and in 46 of these cases, bleeding originiated from varices. Hemodynamic data was available in 19 cases of intrahepatic portal hypertension who had bled from varices. Combined hepatic and umbilicoportal catherterization was perform in 17 cases whereas only hepatic vein catherterization was possible in 2. The portohepatic gradient (FPVP-FHVP or WHVP-FHVP) was utilized as an index of portal hypertension. In the 19 patients studied, the portohepatic gradient ranged from 12 to 24.5 mm Hg with a mean of 18.4 mm Hg; only one patient had a portohepatic gradient of less than 14.5 mm Hg. The present data strongly suggest that in intrahepatic portal hypertension, bleeding varices are observed only if significant portal hypertension exists. Hemodynamic studies may thus be helpful in evaluating bleeding patients with varices particularly when the origin of the bleeding cannot be determined at endoscopy. The finding of a portohepatic gradient of less than 12 mm Hg would strongly suggest that varices were not the source of bleeding and in these cases, shunt surgery should not be considered.

Entities:  

Mesh:

Year:  1975        PMID: 1081459

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  23 in total

Review 1.  Pathophysiology and epidemiology of portal hypertension.

Authors:  H Okumura; T Aramaki; Y Katsuta
Journal:  Drugs       Date:  1989       Impact factor: 9.546

Review 2.  Duplex Doppler ultrasound examination of the portal venous system: an emerging novel technique for the estimation of portal vein pressure.

Authors:  Ashwani K Singal; Masood Ahmad; Roger D Soloway
Journal:  Dig Dis Sci       Date:  2009-07-23       Impact factor: 3.199

3.  Scintigraphic evaluation of hepatic blood flow after intrahepatic portosystemic shunt (TIPS).

Authors:  J Menzel; O Schober; P Reimer; W Domschke
Journal:  Eur J Nucl Med       Date:  1997-06

Review 4.  Modern management of oesophageal varices.

Authors:  P J Gow; R W Chapman
Journal:  Postgrad Med J       Date:  2001-02       Impact factor: 2.401

5.  Palpable spleen and bleeding oesophageal varices.

Authors:  J Bull; P W Keeling; R P Thompson
Journal:  Br Med J       Date:  1979-11-24

Review 6.  Current clinical management of hepatic problems in cystic fibrosis.

Authors:  M S Tanner
Journal:  J R Soc Med       Date:  1986       Impact factor: 5.344

7.  Transjugular intrahepatic portosystemic shunts using the Wallstent prosthesis: a follow-up study.

Authors:  H Rousseau; J P Vinel; J I Bilbao; J M Longo; P Maquin; J M Zozaya; L Garcia-Villareal; B Coustet; N Railhac; J J Railhac
Journal:  Cardiovasc Intervent Radiol       Date:  1994 Jan-Feb       Impact factor: 2.740

Review 8.  Portal circulation and portal hypertension.

Authors:  S Sherlock
Journal:  Gut       Date:  1978-01       Impact factor: 23.059

9.  Drug disposition in patients with HBsAg-positive chronic liver disease.

Authors:  J P Villeneuve; M J Thibeault; M Ampelas; H Fortunet-Fouin; L LaMarre; J Côté; G Pomier-Layrargues; P M Huet
Journal:  Dig Dis Sci       Date:  1987-07       Impact factor: 3.199

10.  The calcium-channel blocker, verapamil, does not improve portal pressure in patients with alcoholic cirrhosis.

Authors:  C Merkel; A Gatta; M Bolognesi; R Padrini; G F Finucci; P Angeli; A Ruol
Journal:  Br J Clin Pharmacol       Date:  1988-09       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.